MOLEMEDD PLUS PRIVATE LIMITED

In their own words

MoleMedd Plus Private Limited: Pioneering Advanced Nuclear Medicine Diagnostics and theranostics MoleMedd Plus Private Limited operates through two leading-edge diagnostic units, NewMedd Diagnostics , Bengaluru and NewMedd Health – Mysuru with a relentless focus on innovation, excellence, and personalized healthcare. NewMedd Diagnostics was established in 2015 as the first standalone center in South India to bring advanced Nuclear Medicine, PET/CT imaging, and radionuclide therapy to the forefront in Bengaluru. It is located at No. 110, KH Road, Opposite Prasiddhi Silks, Bengaluru 560027. By introducing India’s first 5-ring PET/CT scanner in a diagnostic center with unparalleled sensitivity, the widest field of view, and the fastest scanning capabilities, NewMedd Diagnostics has set a new standard in precision molecular imaging. We were also the first to deploy the latest dual-head gamma camera with SPECT. Our commitment didn’t stop at imaging; we are proud to offer personalized radionuclide therapy, we established two isolation wards for high-dose radionuclide therapy in a standalone facility, making us the a facility which was available only a couple of hospitals by then. Since 2016, NewMedd Diagnostics has introduced cutting-edge radiotracers such as Gallium-68 DOTANOC, PSMA, and PRRT therapies, in addition to routine FDG PET/CT scans—yet another pioneering first in standalone centers across India. We have expanded our reach, serving patients not only in Bengaluru but across Karnataka, Tamil Nadu, and Andhra Pradesh, as well as international patients from the Middle East, Africa, Sri Lanka, and the Maldives. In nearly a decade of operations, we have proudly served almost 100,000 patients, providing them with molecular diagnostics and personalized radionuclide therapies. Commitment to Affordable and Inclusive Healthcare We’ve always believed that healthcare should be available to everyone, not just those who can afford it. Around 40-50% of our patients come from public sector hospitals, where they receive our advanced diagnostic and therapeutic services at significantly discounted rates. Our motto is simple yet powerful: No one should be denied healthcare just because of the cost factor. This commitment to affordability and access has earned us the trust of not just individuals, but institutions across regions. Expanding Horizons: NewMedd Health – Mysuru Our second major project under MoleMedd Plus, NewMedd Health, was launched in August 2023 in Mysuru, the Cultural Capital of Karnataka. It is located at No. 59/2, 3d Main, Yadavagiri, Near Akashavani circle, Mysore 570020. True to our vision of bringing world-class healthcare to regional centers, we introduced Digital PET/CT, Digital CT, and MRI services to Mysuru—technologies that were previously unavailable under one roof in the region. This project is poised to significantly reduce the need for patients to travel to Bengaluru for diagnostics and treatment. Continuing our mission of constant innovation, we are soon adding a Dual-head SPECT Gamma Camera, high-end ultrasound equipment, and additional isolation wards for high-dose radionuclide therapy and theranostic services, positioning us at the forefront of nuclear medicine and diagnostic excellence in Southern India. Leadership You Can Trust: Dr. Murali R. Nadig Dr. Murali R. Nadig, Dr. Murali R. Nadig, MBBS, MD is a postgraduate from AIIMS, New Delhi, our Founder, Managing Director, and CEO, is not only a nationally recognized expert in Nuclear Medicine but also a successful serial entrepreneur. In 2008, Dr. Nadig founded Scintilon SPECT Scans, Karnataka’s first standalone nuclear medicine diagnostic center. The center quickly gained prominence for its exceptional services and was acquired by a leading diagnostic chain in 2011. Building on this success, in 2014, Dr. Nadig established MoleMedd Plus Private Limited. Under this venture, he launched NewMedd Diagnostics, a larger and more comprehensive facility, combining nuclear medicine, SPECT, PET/CT, CT, and advanced theranostics for the first time in a standalone center. His entrepreneurial journey has been marked by a consistent drive to bring the latest technologies and highest standards of care to patients. Dr. Nadig’s brings with him two decades of experience in all aspects of Nuclear Medicine, Nuclear Cardiology, PET/CT, hyperthyroidism, thyroid cancer treatment, and radionuclide therapy has earned him national and international recognition. His academic achievements include numerous presentations and publications, and he has been invited to deliver guest lectures at prestigious conferences. Dr. Nadig is supported by a team of highly qualified consultants, each bringing their expertise from some of the most prestigious medical institutions across India. Looking Ahead: Digital Healthcare Transformation We are on the cusp of a new era in healthcare, driven by the latest advancements in digital diagnostics and personalized medicine.

Written by the company on its public Startup India profile. Not verified by us.

Is this your company?

Everything here comes from public government records. If something is wrong, the authoritative place to correct it is the Startup India portal itself, and we will pick the correction up on the next monthly snapshot. To flag an error on our side, use the report link or write to trust@indianstartupmap.com.

How we built this record Where the data comes from How you may reuse it